$CHCI
Comstock Holding Companies, Inc. Stock $chci

$chci Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000129996924000010 Filed on March 21, 2024

Income Statement

Concept	2023 Q4	2023
Revenue	$11.02M	$44.72M
YoY Change	18.43%	13.76%
Cost Of Revenue	$8.479M	$33.04M
YoY Change	16.81%	12.49%
Gross Profit	$2.537M	$11.68M
YoY Change	24.18%	17.49%
Gross Profit Margin	23.03%	26.12%
Selling, General & Admin	$594.0K	$2.305M
YoY Change	51.92%	29.2%
% of Gross Profit	23.41%	19.73%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$12.00K	$212.0K
YoY Change	-78.95%	2.91%
% of Gross Profit	0.47%	1.81%
Operating Expenses	$594.0K	$2.305M
YoY Change	32.59%	29.2%
Operating Profit	$1.943M	$9.164M
YoY Change	21.82%	15.24%
Interest Expense	-$371.0K	-$1.091M
YoY Change	217.09%	980.2%
% of Operating Profit	-19.09%	-11.91%
Other Income/Expense, Net	$31.00K	$79.00K
YoY Change		3850.0%
Pretax Income	$1.603M	$8.152M
YoY Change	8.46%	3.81%
Income Tax	-$267.0K	$368.0K
% Of Pretax Income	-16.66%	4.51%
Net Earnings	$1.870M	$7.784M
YoY Change	43.19%	5.95%
Net Earnings / Revenue	16.98%	17.41%
Basic Earnings Per Share		$0.81
Diluted Earnings Per Share	$0.18	$0.77
COMMON SHARES
Basic Shares Outstanding		9.629M shares
Diluted Shares Outstanding		10.11M shares

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.79M	$18.79M
YoY Change	60.28%	60.28%
Cash & Equivalents	$18.79M	$18.79M
Short-Term Investments
Other Short-Term Assets	$353.0K	$353.0K
YoY Change	33.71%	33.71%
Inventory
Prepaid Expenses
Receivables	$5.245M	$5.245M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$24.39M	$19.14M
YoY Change	54.53%	59.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$478.0K	$7.357M
YoY Change	13.54%	-9.9%
Goodwill
YoY Change
Intangibles	$144.0K
YoY Change	0.0%
Long-Term Investments	$7.077M	$7.077M
YoY Change	0.91%	0.91%
Other Assets	$16.18M	$16.18M
YoY Change	6.82%	6.82%
Total Long-Term Assets	$25.55M	$30.80M
YoY Change	-4.27%	1.02%
TOTAL ASSETS
Total Short-Term Assets	$24.39M	$19.14M
Total Long-Term Assets	$25.55M	$30.80M
Total Assets	$49.94M	$49.94M
YoY Change	17.58%	17.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$838.0K	$838.0K
YoY Change	12.94%	12.94%
Accrued Expenses	$11.81M	$11.81M
YoY Change	-8.3%	-8.3%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.373M	$12.65M
YoY Change	-1.83%	-7.14%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$77.00K	$77.00K
YoY Change
Total Long-Term Liabilities	$77.00K	$77.00K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.373M	$12.65M
Total Long-Term Liabilities	$77.00K	$77.00K
Total Liabilities	$12.72M	$12.72M
YoY Change	-6.58%	-6.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$162.3M
YoY Change	-4.58%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$37.22M	$37.22M
YoY Change
Total Liabilities & Shareholders Equity	$49.94M	$49.94M
YoY Change	17.58%	17.58%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$1.870M	$7.784M
YoY Change	43.19%	5.95%
Depreciation, Depletion And Amortization	$12.00K	$212.0K
YoY Change	-78.95%	2.91%
Cash From Operating Activities	$9.403M	$9.003M
YoY Change	43.67%	11.26%
INVESTING ACTIVITIES
Capital Expenditures	-$53.00K	$247.0K
YoY Change	-179.1%	-60.54%
Acquisitions
YoY Change
Other Investing Activities	-$1.500M	-$1.300M
YoY Change	1227.43%	-11.74%
Cash From Investing Activities	-$1.547M	-$1.547M
YoY Change	759.44%	-26.3%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.00K	-390.0K
YoY Change		-96.14%
NET CHANGE
Cash From Operating Activities	9.403M	9.003M
Cash From Investing Activities	-1.547M	-1.547M
Cash From Financing Activities	10.00K	-390.0K
Net Change In Cash	7.866M	$7.066M
YoY Change	23.58%	-272.3%
FREE CASH FLOW
Cash From Operating Activities	$9.403M	$9.003M
Capital Expenditures	-$53.00K	$247.0K
Free Cash Flow	$9.456M	$8.756M
YoY Change	45.97%	17.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-1164345
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20190
CY2023	dei	City Area Code CityAreaCode	703
CY2023	dei	Security12b Title Security12bTitle	Class A Common Stock, $0.01 par value
CY2023	dei	Trading Symbol TradingSymbol	CHCI
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18788000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	353000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	15781000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7625000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11355000	usd
CY2023Q4	us-gaap	Assets Assets	49939000	usd
CY2023Q4	chci	Accrued Personnel Costs AccruedPersonnelCosts	4681000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	838000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	854000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-170114000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	28854000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42473000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39313000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	29371000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1784000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	206000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	31361000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	7952000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-222000	usd
CY2022	chci	Change In Fair Value Of Equity Method Investment ChangeInFairValueOfEquityMethodInvestment	-121000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	7347000	usd
CY2022	us-gaap	Preferred Stock Redemption Discount PreferredStockRedemptionDiscount	2046000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9393000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8974000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9575000	shares
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.02
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.04
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	7728000	usd
CY2022	chci	Gain Loss On Equity Method Investments Carried At Fair Value GainLossOnEquityMethodInvestmentsCarriedAtFairValue	121000	usd
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	162000	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	55000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39313000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	368000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	7784000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	7728000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-381000	usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001299969
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity File Number EntityFileNumber	001-32375
CY2023	dei	Entity Registrant Name EntityRegistrantName	Comstock Holding Companies, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Local Phone Number LocalPhoneNumber	230-1985
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	11911378	usd
CY2023	dei	Auditor Firm AuditorFirmId	248
CY2023	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2023	dei	Auditor Location AuditorLocation	Arlington, Virginia
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11722000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	264000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	24386000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	478000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	421000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	144000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	144000	usd
CY2023Q4	chci	Leasehold Improvements Net LeaseholdImprovementsNet	89000	usd
CY2022Q4	chci	Leasehold Improvements Net LeaseholdImprovementsNet	119000	usd
CY2023Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	7077000	usd
CY2022Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	7013000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6790000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	10885000	usd
CY2023Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	53000	usd
CY2022Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	0	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	37000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	15000	usd
CY2022Q4	us-gaap	Assets Assets	42473000	usd
CY2022Q4	chci	Accrued Personnel Costs AccruedPersonnelCosts	4959000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	742000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	791000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6373000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6492000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	77000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6273000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7127000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	12723000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	13619000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	202112000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	201535000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	86000	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	86000	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2662000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2662000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-162330000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	37216000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49939000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	44721000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	33040000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2305000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	212000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	35557000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	9164000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	96000	usd
CY2023	chci	Change In Fair Value Of Equity Method Investment ChangeInFairValueOfEquityMethodInvestment	1187000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7784000	usd
CY2023	us-gaap	Preferred Stock Redemption Discount PreferredStockRedemptionDiscount	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	7784000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7784000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	9393000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9629000	shares
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.81
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.77
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.98
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	25296000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-568000	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	4000000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	779000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	7347000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	28854000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	968000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	7784000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	37216000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	7784000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	212000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	206000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	968000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	834000	usd
CY2023	chci	Gain Loss On Equity Method Investments Carried At Fair Value GainLossOnEquityMethodInvestmentsCarriedAtFairValue	-1187000	usd
CY2023	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	44000	usd
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-470000	usd
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	48000	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	0	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-9000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2023	chci	Gain Loss On Deferred Compensation Plan Assets GainLossOnDeferredCompensationPlanAssets	1000	usd
CY2022	chci	Gain Loss On Deferred Compensation Plan Assets GainLossOnDeferredCompensationPlanAssets	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1450000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1932000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	41000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	67000	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-278000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1491000	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	26000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-41000	usd
CY2023	chci	Increase Decrease In Deferred Compensation Plan Liabilities IncreaseDecreaseInDeferredCompensationPlanLiabilities	75000	usd
CY2022	chci	Increase Decrease In Deferred Compensation Plan Liabilities IncreaseDecreaseInDeferredCompensationPlanLiabilities	0	usd
CY2023	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-44000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-192000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	9003000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	8397000	usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1583000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2709000	usd
CY2023	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	1016000	usd
CY2023	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	335000	usd
CY2022	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	220000	usd
CY2023	chci	Payments For Deferred Compensation Plan Securities PaymentsForDeferredCompensationPlanSecurities	52000	usd
CY2022	chci	Payments For Deferred Compensation Plan Securities PaymentsForDeferredCompensationPlanSecurities	0	usd
CY2023	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	247000	usd
CY2022	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	626000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1547000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2099000	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	5500000	usd
CY2023	us-gaap	Payments For Repurchase Of Redeemable Convertible Preferred Stock PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock	0	usd
CY2022	us-gaap	Payments For Repurchase Of Redeemable Convertible Preferred Stock PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock	4000000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	390000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	568000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-390000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-10068000	usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	0	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-305000	usd
CY2023	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	usd
CY2022	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	usd
CY2023	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	0	usd
CY2022	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-26000	usd
CY2023	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	-331000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7066000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4101000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11722000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15823000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18788000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11722000	usd
CY2023	chci	Interest Paid Received Excluding Capitalized Interest Operating Activities InterestPaidReceivedExcludingCapitalizedInterestOperatingActivities	-48000	usd
CY2022	chci	Interest Paid Received Excluding Capitalized Interest Operating Activities InterestPaidReceivedExcludingCapitalizedInterestOperatingActivities	222000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	26000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	92000	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	4230000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1224000	usd
CY2023Q4	chci	Number Of Subsidiaries NumberOfSubsidiaries	4	subsidiary
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Significant items subject to such estimates include, but are not limited to, the valuation of equity method investments, incentive fee revenue recognition, and the valuation of deferred tax assets. Assumptions made in the development of these estimates contemplate both the macroeconomic landscape and the Company's anticipated results, however actual results may differ materially from these estimates.
CY2023	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comstock uses a fiscal reporting calendar which begins on January 1 and ends on December 31. The fiscal years presented are the years ended December 31, 2023 (“2023”) and December 31, 2022 (“2022”). Each of the Company’s fiscal quarters ends on the last day of the calendar month.</span></div>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	200000	usd
CY2023	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income from our automated overnight "sweep account" program investments is recognized on an accrual basis. Interest income is included in "interest income (expense), net" on our consolidated statements of operations.</span></div>
CY2022Q1	chci	Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumerationNotDisclosedFlag	true
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	819000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	761000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	341000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	340000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	478000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	421000	usd
CY2023	us-gaap	Depreciation Depreciation	200000	usd
CY2022	us-gaap	Depreciation Depreciation	200000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	100000	usd
CY2023Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	7077000	usd
CY2022Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	7013000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1186000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1045000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	458000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	361000	usd
CY2023	us-gaap	Lease Cost LeaseCost	1644000	usd
CY2022	us-gaap	Lease Cost LeaseCost	1406000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1588000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1350000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y9M3D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0464
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1167000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1194000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1222000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1203000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1233000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2336000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8355000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1228000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7127000	usd
CY2022Q2	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	4000000	usd
CY2022Q2	us-gaap	Preferred Stock Including Additional Paid In Capital Net Of Discount PreferredStockIncludingAdditionalPaidInCapitalNetOfDiscount	10300000	usd
CY2022Q2	us-gaap	Preferred Stock Redemption Discount PreferredStockRedemptionDiscount	2000000	usd
CY2022Q2	us-gaap	Preferred Stock Redemption Premium PreferredStockRedemptionPremium	8300000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1000000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	800000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	800000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	131000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.08
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	172000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	15000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	11.81
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	116000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.07
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	192000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	116000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.07
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y10M24D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	192000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	600000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	44721000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	44721000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39313000	usd
CY2023	chci	Incentive Fee Revenue IncentiveFeeRevenue	4800000	usd
CY2022	chci	Incentive Fee Revenue IncentiveFeeRevenue	3900000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-102000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	180000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-102000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	180000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1839000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1281000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	178000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-195000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2017000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1086000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1547000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1141000	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	368000	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	125000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7784000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7728000	usd
CY2023	us-gaap	Preferred Stock Redemption Discount PreferredStockRedemptionDiscount	0	usd
CY2022	us-gaap	Preferred Stock Redemption Discount PreferredStockRedemptionDiscount	2046000	usd
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	7784000	usd
CY2023Q4	chci	Deferred Tax Liabilities Right Of Use Lease Asset DeferredTaxLiabilitiesRightOfUseLeaseAsset	1739000	usd
CY2022Q4	chci	Deferred Tax Liabilities Right Of Use Lease Asset DeferredTaxLiabilitiesRightOfUseLeaseAsset	1943000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	38000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1777000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1943000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	10885000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0464
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0567
CY2023	chci	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	0.0050
CY2022	chci	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.0240
CY2023	chci	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	-0.0099
CY2022	chci	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	0.0000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1899
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1454
CY2023	chci	Effective Income Tax Rate Reconciliation Current State Income Taxes EffectiveIncomeTaxRateReconciliationCurrentStateIncomeTaxes	-0.0021
CY2022	chci	Effective Income Tax Rate Reconciliation Current State Income Taxes EffectiveIncomeTaxRateReconciliationCurrentStateIncomeTaxes	-0.0570
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0144
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0245
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0451
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0159
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1500000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	31465000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	33532000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	471000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	481000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	1395000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	1237000	usd
CY2023Q4	chci	Deferred Tax Assets Right Of Use Lease Liability DeferredTaxAssetsRightOfUseLeaseLiability	1825000	usd
CY2022Q4	chci	Deferred Tax Assets Right Of Use Lease Liability DeferredTaxAssetsRightOfUseLeaseLiability	2017000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	1172000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	1246000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-1000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	23666000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	25214000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	12662000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13298000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11355000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	122800000	usd
CY2023	chci	Change In Ownership Of Shareholders In Specified Time ChangeInOwnershipOfShareholdersInSpecifiedTime	P3Y
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	7784000	usd
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	9774000	usd
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	9774000	usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-381000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	7784000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7784000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	9393000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9393000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9629000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8974000	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	479000	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	601000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10108000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9575000	shares
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.81
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.09
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.04
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.81
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.77
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.02
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.04
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.77
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.98
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.03
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.03
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	600000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	500000	usd
CY2023Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	100000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	100000	usd

Files In Submission

Name	View Source	Status
0001299969-24-000010-index-headers.html	Edgar Link	pending
0001299969-24-000010-index.html	Edgar Link	pending
0001299969-24-000010.txt	Edgar Link	pending
0001299969-24-000010-xbrl.zip	Edgar Link	pending
a2023form10-kxex211.htm	Edgar Link	pending
a2023form10-kxex231.htm	Edgar Link	pending
a2023form10-kxex311.htm	Edgar Link	pending
a2023form10-kxex312.htm	Edgar Link	pending
a2023form10-kxex321.htm	Edgar Link	pending
chci-20231231.htm	Edgar Link	pending
chci-20231231.xsd	Edgar Link	pending
ex1025-41marylandavenuep.htm	Edgar Link	pending
ex1025-41marylandavenuep001.jpg	Edgar Link	pending
ex1025-41marylandavenuep002.jpg	Edgar Link	pending
ex1025-41marylandavenuep003.jpg	Edgar Link	pending
ex1025-41marylandavenuep004.jpg	Edgar Link	pending
chci-20231231_lab.xml	Edgar Link	unprocessable
chci-20231231_pre.xml	Edgar Link	unprocessable
chci-20231231_htm.xml	Edgar Link	completed
ex1025-41marylandavenuep005.jpg	Edgar Link	pending
ex1025-41marylandavenuep006.jpg	Edgar Link	pending
ex1025-41marylandavenuep007.jpg	Edgar Link	pending
ex1025-41marylandavenuep008.jpg	Edgar Link	pending
ex1025-41marylandavenuep009.jpg	Edgar Link	pending
ex1025-41marylandavenuep010.jpg	Edgar Link	pending
ex1025-41marylandavenuep011.jpg	Edgar Link	pending
ex1025-41marylandavenuep012.jpg	Edgar Link	pending
ex1025-41marylandavenuep013.jpg	Edgar Link	pending
ex1025-41marylandavenuep014.jpg	Edgar Link	pending
ex1025-41marylandavenuep015.jpg	Edgar Link	pending
ex1025-41marylandavenuep016.jpg	Edgar Link	pending
ex1025-41marylandavenuep017.jpg	Edgar Link	pending
ex1025-41marylandavenuep018.jpg	Edgar Link	pending
ex1026-41marylandsuccess.htm	Edgar Link	pending
ex1026-41marylandsuccess001.jpg	Edgar Link	pending
ex1026-41marylandsuccess002.jpg	Edgar Link	pending
ex1026-41marylandsuccess003.jpg	Edgar Link	pending
ex1026-41marylandsuccess004.jpg	Edgar Link	pending
ex1026-41marylandsuccess005.jpg	Edgar Link	pending
ex97-chciexeccomprecoupm.htm	Edgar Link	pending
ex97-chciexeccomprecoupm001.jpg	Edgar Link	pending
ex97-chciexeccomprecoupm002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
chci-20231231_cal.xml	Edgar Link	unprocessable
chci-20231231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CHCI
Comstock Holding Companies, Inc. Stock $chci

2023 Q4 Form 10-K Financial Statement

#000129996924000010 Filed on March 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHCI Comstock Holding Companies, Inc. Stock $chci

2023 Q4 Form 10-K Financial Statement

#000129996924000010 Filed on March 21, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHCI
Comstock Holding Companies, Inc. Stock $chci